Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus

The study of antiphospholipid antibodies (aPL), not included in the Sydney diagnostic criteria, in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) is poorly understood.The aim of this study – to determine the clinical significance of IgG antibody testing for domain I β2 -glyco...

Full description

Saved in:
Bibliographic Details
Main Authors: F. A. Cheldieva, T. M. Reshetnyak, M. V. Cherkasova, S. I. Glukhova, A. M. Lila, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2022-07-01
Series:Научно-практическая ревматология
Subjects:
antiphospholipid antibodies
antiphospholipid syndrome
antibodies to domain i β2 -glycoprotein 1
pregnancy morbidity
thrombosis
Online Access:https://rsp.mediar-press.net/rsp/article/view/3184
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rsp.mediar-press.net/rsp/article/view/3184

Similar Items